MARTINI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 552
NA - Nord America 352
AS - Asia 107
SA - Sud America 8
AF - Africa 3
OC - Oceania 1
Totale 1.023
Nazione #
US - Stati Uniti d'America 350
IT - Italia 331
SE - Svezia 142
JP - Giappone 41
CN - Cina 25
IN - India 23
FI - Finlandia 13
TR - Turchia 13
DE - Germania 9
BR - Brasile 8
FR - Francia 8
ES - Italia 7
GB - Regno Unito 7
IE - Irlanda 7
NL - Olanda 5
GR - Grecia 4
PL - Polonia 4
BG - Bulgaria 3
LT - Lituania 3
AT - Austria 2
HK - Hong Kong 2
NG - Nigeria 2
NO - Norvegia 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
CA - Canada 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 1.023
Città #
Ashburn 116
New York 64
Milan 46
Lawrence 28
Princeton 28
Rome 27
Shanghai 25
Pune 20
Helsinki 13
Turin 13
Bologna 9
Florence 8
Bursa 7
Dublin 7
Bari 6
Tokyo 6
Falconara Marittima 5
Lamezia Terme 5
Naples 5
Palermo 5
Paris 5
Amsterdam 4
Arcore 4
Genoa 4
Padova 4
Seattle 4
Washington 4
Andria 3
Athens 3
Bilbao 3
Bolzano 3
Gohongi 3
Istanbul 3
Shibuya 3
The Bronx 3
Trieste 3
Verona 3
Ancona 2
Barcelona 2
Borås 2
Cancello e Arnone 2
Castel Gandolfo 2
Chiampo 2
Chiyoda-ku 2
Ciserano 2
Cologne 2
Cordenons 2
Ferrara 2
Frankfurt am Main 2
Hanawada 2
Hanoi 2
Hanover 2
Holyhead 2
Hong Kong 2
Hyderabad 2
Jales 2
Kaunas 2
Lecce 2
London 2
Messina 2
Miami 2
Modena 2
Moncalieri 2
Mushin 2
Niigata 2
Nogara 2
Palhoca 2
Pisa 2
Porto Alegre 2
Quartu Sant'Elena 2
Redwood City 2
Rimini 2
Sant'Elena 2
Sant'Ilario d'Enza 2
Santeramo in Colle 2
Sharon 2
Sofia 2
Sommacampagna 2
Syracuse 2
São Paulo 2
Tangen 2
Tenri 2
Toulon 2
Treviso 2
Tusa 2
Vienna 2
Bagheria 1
Banská Bystrica 1
Belgorod 1
Bergamo 1
Blida 1
Brescia 1
Calgary 1
Campi Bisenzio 1
Cartagena 1
Cervignano del Friuli 1
Chalcis 1
Chiba 1
Christchurch 1
Colne 1
Totale 614
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 420
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 28
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 25
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 24
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 23
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
How to Select the Optimal Candidates for Renal Mass Biopsy 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 22
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 22
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 22
A Plea for Economically Sustainable Evidence-based Guidelines 21
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 20
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 20
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 20
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 19
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 19
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 19
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 17
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 17
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 16
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 16
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 16
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 15
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 13
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 12
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 12
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 12
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 12
The obesity paradox in metastatic castration-resistant prostate cancer 12
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 12
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 11
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 11
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 10
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 10
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 6
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 6
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 6
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 3
null 1
Totale 1.062
Categoria #
all - tutte 6.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 1 0 0 0 1 0 0 0
2020/202110 0 0 0 0 0 8 2 0 0 0 0 0
2021/2022109 0 9 1 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024556 18 21 31 50 53 133 41 156 12 41 0 0
Totale 1.062